PneumRx logo — Innovative solutions for minimally invasive emphysema treatm...

PneumRx

Innovative solutions for minimally invasive emphysema treatment with a pioneering lung volume reduction device.

Founded 2004 Venture round Total: $73.13M Biotechnology, Health Care +1

General Information

Company Name PneumRx
Founded Year 2004
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with PneumRx. To contact PneumRx, visit pneumrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About PneumRx

PneumRx, Inc. is a startup focusing on medical devices and dedicated to developing minimally invasive treatments for emphysema patients. Established in 2004 and based in Mountain View, California, the company has made significant strides in the biotechnology, healthcare, and medical devices industries. Their flagship product, the RePneu Lung Volume Reduction Coil, shows promising potential in addressing emphysema. The company's last funding round in January 2011 amounted to a substantial $33.00M and was backed by a consortium of notable investors including Adams Street Partners, Alta Partners, Forbion, Endeavour Vision, Telegraph Hill Partners, Leader Ventures, Spray Venture Partners, and Silicon Valley Bank. This investment underscores the potential of PneumRx and its pioneering approach to emphysema treatment.

Taxonomy: PneumRx, Emphysema Treatment, Lung Volume Reduction, Minimally Invasive Procedures, Healthcare Innovation, Medical Technology, Startup, Mountain View, California, Pioneering Device, Lung Disease, Treatment Innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $33.00M 8
Adams Street Partners, Alta Partners +6
04 Jan 2011
Series B $27.00M 2
Alta Partners, Spray Venture Partners
06 Mar 2007
Series A $10.73M -
14 Jun 2005
Series A $2.40M -
22 Nov 2004

PneumRx Alternatives & Competitors

View All Alternatives
PneumRx vs

Pioneering the future of minimally-invasive pulmonology, enhancing early-stage diagnosis and treatme...

Venture round
Health Care, Medical Devices
PneumRx vs

Pioneering minimally invasive mitral valve repair solutions for effective heart disease treatment

Series D
1 employees
Health Care, Medical Devices
PneumRx vs

Pioneering non-invasive solutions for treating uterine fibroids, empowering gynecologists to heal wi...

Debt Financing
Health Care, Health and Wellness

FAQ About PneumRx

Innovative solutions for minimally invasive emphysema treatment with a pioneering lung volume reduction device.
PneumRx was founded in 2004.
PneumRx operates in Biotechnology, Health Care and Medical Devices. Its work centres on PneumRx, Emphysema Treatment, Lung Volume Reduction and Minimally Invasive Procedures.
PneumRx has completed 4 funding rounds, raising a total of $73.13M. The latest funding stage is Venture round.
Top alternatives and competitors to PneumRx include SuperDimension, Hanyu Medical, Mirabilis Medical, TARIS, Taurus Vascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PneumRx and SuperDimension are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PneumRx, https://bouncewatch.com/company/pneumrx, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes